- Appointments will support GHO through deal origination and portfolio company support, bringing extensive experience in market access, MedTech and advanced therapies from industry and consulting careers.
London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in healthcare, announces the appointment of David Miller and Geoffrey Hamilton-Fairley as Operating Partners. Both will leverage their extensive operational expertise and professional networks to support deal origination as well as GHO’s portfolio companies, many of which they already have close working relationships with.
David Miller was formerly Senior Vice President of Global Market Access at Biogen with responsibility for the global pricing, reimbursement and access of Biogen’s product portfolio, before founding his own advisory practice whose clients have included large, midsize and start-up biotechs.
Geoffrey Hamilton-Fairley has extensive experience of investing in, and leading companies at different stages of development from start-ups through to sale and IPO, with particular experience within MedTech and advanced therapies.His experience includes developing and guiding Oncimmune, a company pioneering technologies to enable early cancer detection, from a Nottingham University start-up through to a successful IPO in May 2016.
The Partners at GHO commented: “We are pleased to welcome David and Geoffrey to our team at what is an exciting time for the firm. Their track record within the industry speaks for itself, and we look forward to working closely with them both to support our existing portfolio and identify new opportunities. Against a difficult backdrop, GHO continues to see strong investor demand, built on robust performance from our portfolio and a busy pipeline of bolt-on and platform investment activity.”